Blackrock Health Sciences Trust is a US-based company operating in industry. The company is headquartered in Wilmington, Delaware. The company went IPO on 2005-03-29. BlackRock Health Sciences Trust (the Trust) is a closed-end management investment company. The Trust investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust seeks to pursue this goal primarily by investing in a portfolio of equity securities and by employing a strategy of writing (selling) call and put options. The Trust invests in a portfolio of sectors, which include pharma, biotech and life sciences; healthcare equipment and services; semiconductors & semiconductor equipment; financial services, and others. BlackRock Advisors, LLC acts as the investment adviser of the Trust.
最新の財務諸表(Form-10K)によると、Blackrock Health Sciences Trustの総資産は$0で、純損失は$0です。
BMEの主要な財務比率は何ですか?
Blackrock Health Sciences Trustの流動比率は0、純利益率は0、1株当たり売上高は$0です。
Blackrock Health Sciences Trustの収益はセグメントまたは地域別にどのように分けられていますか?
Blackrock Health Sciences Trust の最大収益セグメントは Tommy Bahama で、最新の利益発表における収益は 898,807,000 です。地域別に見ると、United States が Blackrock Health Sciences Trust の主要市場であり、収益は 1,532,100,000 です。
Blackrock Health Sciences Trustは収益を上げていますか?
いいえ、最新の財務諸表によると、Blackrock Health Sciences Trustの純損失は$0です。